Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
accent therapeutics
aducanumab
1
×
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
1
×
cancer
cara therapeutics
deerfield management
detroit blog main
detroit top stories
drug development
drug discovery
esperion
europe blog main
europe top stories
fda
financing
gilead sciences
immunomedics
incyte
1
×
indiana blog main
indiana top stories
ipo
kite
korsuva
lantern pharma
laura shawver
life sciences
matthew klein
1
×
melinta therapeutics
What
activity
approvals
bio
biogen
clamped
covid
delays
developing
1
×
economic
fast
fda
including
ipo
isn’t
lot
medicines
new
oric’s
roundup
showing
spread
testing
work
Language
unset
Current search:
aducanumab
×
national
×
developing
×
" c. greg guyer "
×
incyte
×
" matthew klein "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More